Bausch & Lomb (BLCO) Shares Outstanding (Diluted Average) (2021 - 2026)
Bausch & Lomb (BLCO) reported Shares Outstanding (Diluted Average) of $355.2 million for Q1 2026, up 0.68% on a YoY basis from $352.8 million in Q1 2025, and little changed quarter-over-quarter from $353.8 million in Q4 2025.
Bausch & Lomb (BLCO) Shares Outstanding (Diluted Average) (2021 - 2026) Analysis & Trends
Bausch & Lomb has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $355.2 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 0.68% year-over-year to $355.2 million; the trailing twelve-month figure through Mar 2026 stood at $355.2 million (up 0.68% YoY), and the FY2025 full-year result was $353.8 million, up 0.57% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $355.2 million, roughly flat from $353.8 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $355.2 million in Q1 2026, with the low at $350.0 million in Q1 2022.
- Historically, Shares Outstanding (Diluted Average) has averaged $351.6 million across 5 years, with a median of $351.1 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) changed 0.0% — and 2025, when it rose 0.71%.
- Bausch & Lomb's Shares Outstanding (Diluted Average) stood at $350.2 million in 2022, then increased by 0.09% to $350.5 million in 2023, then grew by 0.37% to $351.8 million in 2024, then gained by 0.57% to $353.8 million in 2025, then advanced by 0.4% to $355.2 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $355.2 million (Q1 2026), $353.8 million (Q4 2025), and $354.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 824.84 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.72 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 175.50 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.61 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Bausch & Lomb | 5.32 Bn | 5.12 Bn | 973.00 Mn | 355.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 355.20 Mn |
| Dec 31, 2025 | 353.80 Mn |
| Sep 30, 2025 | 354.20 Mn |
| Jun 30, 2025 | 353.70 Mn |
| Mar 31, 2025 | 352.80 Mn |
| Dec 31, 2024 | 351.80 Mn |
| Sep 30, 2024 | 351.70 Mn |
| Jun 30, 2024 | 351.50 Mn |
| Mar 31, 2024 | 351.10 Mn |
| Dec 31, 2023 | 350.50 Mn |
| Sep 30, 2023 | 350.40 Mn |
| Jun 30, 2023 | 350.30 Mn |
| Mar 31, 2023 | 350.00 Mn |
| Dec 31, 2022 | 350.20 Mn |
| Sep 30, 2022 | 350.00 Mn |
| Jun 30, 2022 | 350.00 Mn |
| Mar 31, 2022 | 350.00 Mn |
| Dec 31, 2021 | 350.00 Mn |
| Sep 30, 2021 | 350.00 Mn |
| Jun 30, 2021 | 350.00 Mn |